Glados 15 Mg 30 Tablet

Glados 15 Mg 30 Tablet: Advanced Management for Type 2 Diabetes Mellitus

Glados 15 Mg 30 Tablet is a vital prescription medication designed for the comprehensive management of Type 2 Diabetes Mellitus in adults.
This oral tablet contains Pioglitazone, an active ingredient belonging to the thiazolidinedione (TZD) class of antidiabetic agents.
By targeting insulin resistance, Glados helps the body respond better to its own insulin, leading to improved blood sugar control.
It is an integral part of a holistic treatment plan that typically includes diet, exercise, and sometimes other antidiabetic medications.
Consistent use, as directed by a healthcare professional, supports patients in achieving and maintaining optimal glycemic levels, thereby reducing the risk of diabetes-related complications.

Benefits of Use

• Significantly improves insulin sensitivity in muscle, adipose tissue, and the liver, allowing for more efficient glucose uptake and utilization.
• Effectively lowers both fasting and post-meal blood sugar levels.
• Helps to achieve and sustain better glycemic control (measured by HbA1c levels) over time.
• Can be used as monotherapy or in combination with other antidiabetic agents such as metformin or sulfonylureas, as prescribed by a physician.
• Contributes to a reduced burden on the pancreas by improving existing insulin function.

How to Use

1. Always take Glados 15 Mg 30 Tablet exactly as prescribed by your doctor.
2. The typical starting dose is 15 mg or 30 mg once daily, but your doctor will determine the appropriate dosage for you.
3. Glados tablets can be taken with or without food.
4. Swallow the tablet whole with a glass of water; do not crush, chew, or break it.
5. It is advisable to take the medication at the same time each day to help maintain consistent blood sugar levels.
6. Regular blood glucose monitoring is crucial while on this medication, as directed by your healthcare provider.
7. Continue to follow your prescribed diet and exercise program alongside Glados therapy.

Caution & Warnings

• Before starting Glados, inform your doctor about any history of heart failure, liver problems, or bladder cancer.
• Pioglitazone can cause or worsen heart failure. Report any symptoms such as shortness of breath, rapid weight gain, or swelling in your ankles or feet immediately to your doctor.
• Close monitoring of liver function is recommended, especially before and during treatment. Discontinue if signs of liver injury appear.
• An increased risk of bladder cancer has been observed with Pioglitazone; discuss this risk with your doctor.
• Female patients may have an increased risk of bone fractures (e.g., in the upper arm, hand, or foot); discuss bone health with your doctor.
• Hypoglycemia (low blood sugar) can occur, especially when Glados is taken with insulin or sulfonylureas. Be aware of the symptoms and how to manage them.
• This medication is not for Type 1 Diabetes or for treating diabetic ketoacidosis.
• Do not stop taking Glados without consulting your doctor, even if you feel well.
• Keep out of reach of children.
• Store in a cool, dry place away from direct light and moisture.

Ingredients

• Active Ingredient: Pioglitazone 15 mg
• Excipients: (e.g., Lactose monohydrate, Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate, etc. - specific excipients may vary by manufacturer).

Product Details

• Brand: Glados
• Strength: 15 mg
• Dosage Form: Oral Tablet
• Package Size: 30 Tablets
• Drug Type: Prescription Medication
• Manufacturer: EVA Pharma